A detailed history of Adviser Investments LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Adviser Investments LLC holds 3,056 shares of MRNA stock, worth $200,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,056
Previous 3,056 -0.0%
Holding current value
$200,932
Previous $325,000 11.38%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$85.37 - $115.44 $72,137 - $97,546
845 Added 38.22%
3,056 $325,000
Q4 2023

Feb 01, 2024

BUY
$69.51 - $104.43 $153,686 - $230,894
2,211 New
2,211 $219,000
Q4 2021

Jan 31, 2022

SELL
$225.82 - $368.51 $171,171 - $279,330
-758 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$221.9 - $484.47 $168,200 - $367,228
758 New
758 $292,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Adviser Investments LLC Portfolio

Follow Adviser Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adviser Investments LLC with notifications on news.